Seattle University Search | Site Index | Directories | Contact
Albers School of Business and Economics

Pigott Building, (206)296-5700

 

About Albers

Albers Mentor Program
Participating Mentors 2008-2009

Mr. Jim Fitzsimmons

CEO
Archus Orthopedics, Inc.

Industry: Medical Devices

Description of Company:

Archus Orthopedics, Inc.

Founded in July 2001, Archus Orthopedics is a privately held company developing a family of reconstructive implants to treat a variety of spine disorders resulting from degenerative changes in the facet joints. Archus Orthopedics, Inc. began U.S. clinical trials of its Total Facet Arthroplasty System (TFAS) in August 2005. The TFAS is a novel, patented spinal implant designed to treat spinal stenosis, a condition in which degenerative changes in the facet joints result in compression of spinal nerves producing neurological symptoms in the legs. Traditionally, patients with spinal stenosis undergo decompressive laminectomy surgery, which is often accompanied by spinal fusion. The TFAS replaces the degenerative facet joints with a prosthetic joint implant intended to restore stability and normal motion to the spine, eliminating the need for fusion.

Areas of Responsibility - Job Description: 

Chairman and CEO, Archus Orthopedics, Inc.
Co-Founder and Board member, Cardiac Dimensions, Inc.
Co-Founder, EndoGastric Solutions, Inc.

Areas of Expertise - Employment History: 

Jim Fitzsimmons is Chairman and Chief executive Officer of Archus Orthopedics, Inc., a start-up medical device company developing a novel implantable device to treat degenerative diseases of the lumbar spine. Prior to Archus, Jim was the Founder and Managing Director of Scout Medical Technologies, LLC, a medical device incubation firm. In association with his work at Scout, Jim co-founded and continues as a Board member of Cardiac Dimensions, Inc. and EndoGastric Solutions, Inc., both start-up medical device companies. He also engineered Scouts investment and management relationship with his current company. Prior to Scout, Jim served as Senior Vice President and General Manager of Guidant Corporations Cardiac and Vascular Surgery Group. He joined Guidant in 1997 as a result of its acquisition of EndoVascular Technologies ("EVT").

Jim was President and Chief Executive Officer of EVT for six years prior to the Guidant acquisition. Before that, Jim spent eleven years with the Medical Device and Diagnostic Division of Eli Lilly and Company. During his tenure at Lilly, Jim held a variety of positions in sales, marketing, mergers and acquisitions, and general management. Outside of his relationship with the Scout companies, Jim is a member of the Board of Directors of VNUS Medical Technologies, a publicly traded company, as well as Broncus, Inc. and Asthmatx, Inc., both privately held medical device companies.

Education - Personal History: 

BS Biology Pre-Med, Seattle University, 1978
MBA, Seattle University, 1984

Civic Organization Memberships or Professional Affiliations: 

Serves on the Advisory Board of the Albers School of Business and Center for Entrepreneurship at Seattle University.

When and Where do you hold meetings with students? 

Redmond, WA

Mentor since Fall 2002
Will mentor graduate students



The Albers School is AACSB accredited

 

Seattle University   901 - 12th Avenue, P.O. Box 222000, Seattle, WA 98122-1090    (206) 296-6000